Na+-induced Ca2++ influx through reverse mode of Na+-Ca2++ exchanger in mouse ventricular cardiomyocyte

Zhen Yu Yan, Tao Ban, Yao Fan, Wei Ran Chen, Hong Li Sun, Hanying Chen, Quo Fen Qiao, Bai Yan Li

Research output: Contribution to journalArticle

Abstract

Background: Dobutamine is commonly used for clinical management of heart failure and its pharmacological effects have long been investigated as inotropics via β-receptor activation. However, there is no electrophysiological evidence if dobutamine contributes inotropic action due at least partially to the reverse mode of Na+-Ca2++ exchanger (NCX) activation. Methods: Action potential (AP), voltage-gated Na+ (INa), Ca2++ (ICa), and K+ (Ito and IK1) currents were observed using whole-cell patch technique before and after dobutamine in ventricular cardiomyocytes isolated from adult mouse hearts. Another sets of observation were also performed with Kb-r7943 or in the solution without [Ca2++]o. Results: Dobutamine (0.1-1.0 μM) significantly enhanced the AP depolarization with prolongation of AP duration (APD) in a concentration-dependent fashion. The density of INa was also increased concentration-dependently without alternation of voltage-dependent steady-status of activation and inactivation, reactivation as well. Whereas, the activities for ICa, Ito, and IK1 were not changed by dobutamine. Intriguingly, the dobutamine-mediated changes in AP repolarization were abolished by 3 μM Kb-r7943 pretreatment or by simply removing [Ca2++]o without affecting accelerated depolarization. Additionally, the ratio of APD50/APD90 was not significantly altered in the presence of dobutamine, implying that effective refractory period was remain unchanged. Conclusion: This novel finding provides evidence that dobutamine upregulates of voltage-gated Na+ channel function and Na+ influx-induced activation of the reverse mode of NCX, suggesting that dobutamine may not only accelerate ventricular contraction via fast depolarization but also cause Ca2++ influx, which contributes its positive inotropic effect synergistically with β-receptor activation without increasing the arrhythmogenetic risk.

Original languageEnglish (US)
Pages (from-to)23272-23280
Number of pages9
JournalOncotarget
Volume6
Issue number27
DOIs
StatePublished - 2015
Externally publishedYes

Fingerprint

Dobutamine
Cardiac Myocytes
Action Potentials
Up-Regulation
Heart Failure
Observation
Pharmacology

Keywords

  • Action potential
  • Dobutamine
  • Pathology Section
  • Reverse mode of Na-Ca+ exchanger
  • Ventricular cardiomyocyte
  • Voltage-gated ion channel

ASJC Scopus subject areas

  • Oncology

Cite this

Na+-induced Ca2++ influx through reverse mode of Na+-Ca2++ exchanger in mouse ventricular cardiomyocyte. / Yan, Zhen Yu; Ban, Tao; Fan, Yao; Chen, Wei Ran; Sun, Hong Li; Chen, Hanying; Qiao, Quo Fen; Li, Bai Yan.

In: Oncotarget, Vol. 6, No. 27, 2015, p. 23272-23280.

Research output: Contribution to journalArticle

Yan, Zhen Yu ; Ban, Tao ; Fan, Yao ; Chen, Wei Ran ; Sun, Hong Li ; Chen, Hanying ; Qiao, Quo Fen ; Li, Bai Yan. / Na+-induced Ca2++ influx through reverse mode of Na+-Ca2++ exchanger in mouse ventricular cardiomyocyte. In: Oncotarget. 2015 ; Vol. 6, No. 27. pp. 23272-23280.
@article{38936e26137b494ea45e57ff512af156,
title = "Na+-induced Ca2++ influx through reverse mode of Na+-Ca2++ exchanger in mouse ventricular cardiomyocyte",
abstract = "Background: Dobutamine is commonly used for clinical management of heart failure and its pharmacological effects have long been investigated as inotropics via β-receptor activation. However, there is no electrophysiological evidence if dobutamine contributes inotropic action due at least partially to the reverse mode of Na+-Ca2++ exchanger (NCX) activation. Methods: Action potential (AP), voltage-gated Na+ (INa), Ca2++ (ICa), and K+ (Ito and IK1) currents were observed using whole-cell patch technique before and after dobutamine in ventricular cardiomyocytes isolated from adult mouse hearts. Another sets of observation were also performed with Kb-r7943 or in the solution without [Ca2++]o. Results: Dobutamine (0.1-1.0 μM) significantly enhanced the AP depolarization with prolongation of AP duration (APD) in a concentration-dependent fashion. The density of INa was also increased concentration-dependently without alternation of voltage-dependent steady-status of activation and inactivation, reactivation as well. Whereas, the activities for ICa, Ito, and IK1 were not changed by dobutamine. Intriguingly, the dobutamine-mediated changes in AP repolarization were abolished by 3 μM Kb-r7943 pretreatment or by simply removing [Ca2++]o without affecting accelerated depolarization. Additionally, the ratio of APD50/APD90 was not significantly altered in the presence of dobutamine, implying that effective refractory period was remain unchanged. Conclusion: This novel finding provides evidence that dobutamine upregulates of voltage-gated Na+ channel function and Na+ influx-induced activation of the reverse mode of NCX, suggesting that dobutamine may not only accelerate ventricular contraction via fast depolarization but also cause Ca2++ influx, which contributes its positive inotropic effect synergistically with β-receptor activation without increasing the arrhythmogenetic risk.",
keywords = "Action potential, Dobutamine, Pathology Section, Reverse mode of Na-Ca+ exchanger, Ventricular cardiomyocyte, Voltage-gated ion channel",
author = "Yan, {Zhen Yu} and Tao Ban and Yao Fan and Chen, {Wei Ran} and Sun, {Hong Li} and Hanying Chen and Qiao, {Quo Fen} and Li, {Bai Yan}",
year = "2015",
doi = "10.18632/oncotarget.4878",
language = "English (US)",
volume = "6",
pages = "23272--23280",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals",
number = "27",

}

TY - JOUR

T1 - Na+-induced Ca2++ influx through reverse mode of Na+-Ca2++ exchanger in mouse ventricular cardiomyocyte

AU - Yan, Zhen Yu

AU - Ban, Tao

AU - Fan, Yao

AU - Chen, Wei Ran

AU - Sun, Hong Li

AU - Chen, Hanying

AU - Qiao, Quo Fen

AU - Li, Bai Yan

PY - 2015

Y1 - 2015

N2 - Background: Dobutamine is commonly used for clinical management of heart failure and its pharmacological effects have long been investigated as inotropics via β-receptor activation. However, there is no electrophysiological evidence if dobutamine contributes inotropic action due at least partially to the reverse mode of Na+-Ca2++ exchanger (NCX) activation. Methods: Action potential (AP), voltage-gated Na+ (INa), Ca2++ (ICa), and K+ (Ito and IK1) currents were observed using whole-cell patch technique before and after dobutamine in ventricular cardiomyocytes isolated from adult mouse hearts. Another sets of observation were also performed with Kb-r7943 or in the solution without [Ca2++]o. Results: Dobutamine (0.1-1.0 μM) significantly enhanced the AP depolarization with prolongation of AP duration (APD) in a concentration-dependent fashion. The density of INa was also increased concentration-dependently without alternation of voltage-dependent steady-status of activation and inactivation, reactivation as well. Whereas, the activities for ICa, Ito, and IK1 were not changed by dobutamine. Intriguingly, the dobutamine-mediated changes in AP repolarization were abolished by 3 μM Kb-r7943 pretreatment or by simply removing [Ca2++]o without affecting accelerated depolarization. Additionally, the ratio of APD50/APD90 was not significantly altered in the presence of dobutamine, implying that effective refractory period was remain unchanged. Conclusion: This novel finding provides evidence that dobutamine upregulates of voltage-gated Na+ channel function and Na+ influx-induced activation of the reverse mode of NCX, suggesting that dobutamine may not only accelerate ventricular contraction via fast depolarization but also cause Ca2++ influx, which contributes its positive inotropic effect synergistically with β-receptor activation without increasing the arrhythmogenetic risk.

AB - Background: Dobutamine is commonly used for clinical management of heart failure and its pharmacological effects have long been investigated as inotropics via β-receptor activation. However, there is no electrophysiological evidence if dobutamine contributes inotropic action due at least partially to the reverse mode of Na+-Ca2++ exchanger (NCX) activation. Methods: Action potential (AP), voltage-gated Na+ (INa), Ca2++ (ICa), and K+ (Ito and IK1) currents were observed using whole-cell patch technique before and after dobutamine in ventricular cardiomyocytes isolated from adult mouse hearts. Another sets of observation were also performed with Kb-r7943 or in the solution without [Ca2++]o. Results: Dobutamine (0.1-1.0 μM) significantly enhanced the AP depolarization with prolongation of AP duration (APD) in a concentration-dependent fashion. The density of INa was also increased concentration-dependently without alternation of voltage-dependent steady-status of activation and inactivation, reactivation as well. Whereas, the activities for ICa, Ito, and IK1 were not changed by dobutamine. Intriguingly, the dobutamine-mediated changes in AP repolarization were abolished by 3 μM Kb-r7943 pretreatment or by simply removing [Ca2++]o without affecting accelerated depolarization. Additionally, the ratio of APD50/APD90 was not significantly altered in the presence of dobutamine, implying that effective refractory period was remain unchanged. Conclusion: This novel finding provides evidence that dobutamine upregulates of voltage-gated Na+ channel function and Na+ influx-induced activation of the reverse mode of NCX, suggesting that dobutamine may not only accelerate ventricular contraction via fast depolarization but also cause Ca2++ influx, which contributes its positive inotropic effect synergistically with β-receptor activation without increasing the arrhythmogenetic risk.

KW - Action potential

KW - Dobutamine

KW - Pathology Section

KW - Reverse mode of Na-Ca+ exchanger

KW - Ventricular cardiomyocyte

KW - Voltage-gated ion channel

UR - http://www.scopus.com/inward/record.url?scp=84943403872&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943403872&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.4878

DO - 10.18632/oncotarget.4878

M3 - Article

C2 - 26314851

AN - SCOPUS:84943403872

VL - 6

SP - 23272

EP - 23280

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 27

ER -